55745-96-5 Usage
General Description
6-Benzofurancarboxaldehyde, 2,3-dihydro- (9CI) is a chemical compound with the molecular formula C10H10O2. It is an aromatic aldehyde with a benzofuran ring structure. 6-Benzofurancarboxaldehyde, 2,3-dihydro- (9CI) is commonly used in the synthesis of pharmaceuticals, fragrances, and other organic compounds. It is known for its strong and distinct odor, which makes it useful in the production of scented consumer products. Additionally, it has been studied for its potential medicinal properties, including its antimicrobial and antifungal activities. However, it is important to handle this chemical with care, as it can be irritating to the skin, eyes, and respiratory system, and may be toxic if ingested or inhaled in large quantities.
Check Digit Verification of cas no
The CAS Registry Mumber 55745-96-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,7,4 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 55745-96:
(7*5)+(6*5)+(5*7)+(4*4)+(3*5)+(2*9)+(1*6)=155
155 % 10 = 5
So 55745-96-5 is a valid CAS Registry Number.
55745-96-5Relevant articles and documents
SPIRO COMPOUNDS AS GLYCOSIDASE INHIBITORS
-
Paragraph 106; 107, (2020/03/15)
Compounds of formula (I) wherein A, R, L, Z, Q1, Q2 and n have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.
FUSED GLYCOSIDASE INHIBITORS
-
Page/Page column 118, (2020/09/08)
Compounds of formula (I), wherein A, Z, E, R1, R2, m and n have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.
ANNULATED GLYCOSIDASE INHIBITORS
-
Page/Page column 91, (2019/03/12)
Compounds of formula (I) wherein A, R, W1, W2, W3, W4, W5, W6, L, Q, Rx and u have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.